Take Action Online Now Action Alerts
In the last several years, medical cannabis patients have been protected by an appropriations rider known as the Rohrabacher-Farr Amendment which has prevented the Department of Justice from interfering with state medical cannabis programs and patients. Lawmakers are already fighting to include protections for medical cannabis patients for FY 2018, but the remainder of this fiscal year remains uncertain.
Committees will be voting in Annapolis any day now on a series of bills that will further delay patient access to medical cannabis. All Maryland residents if you haven't already, please join us in calling on our leaders to allow the current process to move forward so we can open for business and begin helping patients in need. Patients are suffering NOW, and it’s time to roll out this program.
It is less than two weeks until the 2016 elections. Do you know where the candidates stand on medical cannabis? It matters. Lawmakers at the local, state and federal level are going to make important decisions about medical cannabis that affect your life in the next two years. Cities and counties will decide whether to ban or regulate patient safe access, state legislatures will vote on commercial licensing and patients’ rights measures, and the new US Congress may decide whether or not to keep paying for medical cannabis enforcement.
Today ASA is relaunching our updated MMJ Voter’s Guide and voter education website. We have analyzed the voting records of every Member of Congress to create an educational guide about the voting records of each House Representative and Senator. We have also announced the organization’s positions on each of the medical and adult-use ballot measures.
ASA is interested in finding out how our members feel about their state medical cannabis programs. We are inviting you take our 2016 Patient and Caregiver Survey, which will ultimately be part of the 2016 version of our Medical Marijuana Access in the U.S. report.
Currently, medical cannabis patients in the District of Columbia are forced to chose a single dispensary to make all of their purchases. This means that if a dispensary runs out of a certain strain or product, patients cannot visit the other DC dispensaries to get the strains and products that work best for them. Patients in DC deserve access to the full array of medical cannabis products in the district, but the law currently prevents patients from experiencing this benefit.
There will be an opportunity to fix this problem on Tuesday, October 10th, when the reciprocity and lab testing bill heads to First Reading before the Council. We are asking the Council to introduce an amendment to strike this unnecessary provision from the law.
The good news is that the Rohrabacher-Farr amendment to the Department of Justice’s (DOJ) budget has been extended. This amendment has been helping medical cannabis defendants win in federal court. Beginning with the Marin Alliance for Medical Marijuana ruling last October, to dropping the case against Harborside this May, to the McIntosh victory in the 9th Circuit in August, the amendment has been protecting safe and legal access for patients.
Unfortunately, the amendment must be passed again every year to remain in effect and was set to expire at the end of the month. While Congress has just extended the protections along with the rest of last year’s appropriations bill, the protections must be renewed again before December 9th of this year.
We need to make sure the Rohrabacher-Farr amendment stays in the final bill in December. Better yet, Congress could pass the CARERS Act, which would permanently fix the conflict between state and federal medical cannabis laws.
As you probably know, the Drug Enforcement Administration (DEA) released its decision to keep cannabis in its current Schedule I status. Of course, we all know this is ridiculous!
ASA has just published a report challenging lengthy decision determination issued by the DEA. While Schedule I status means the DEA sees no accepted medical use of cannabis, ASA found that the DEA cited flawed data while ignoring many useful studies published since 2001. If the DEA is looking at bad science while turning a blind eye to recent research, it’s no wonder they came to such an absurd determination.
There is only ONE THING left to ensure patients are protected AND research on medical cannabis moves forward and that is PASS THE CARERS ACT! We need YOU, to contact your legislators TODAY and tell them you want them to support the CARERS Act.
Please take a moment to send this pre-written email to your reps and senators in Congress urging them to support the CARERS Act.
Congress is on summer break and now is the perfect time for you to arrange meetings in your district offices. With four simple steps you can help educate and inform legislators of the growing need for an alternate treatment for the millions of patients suffering from pain every day.
Here’s how you can help:
Step 1: Send the pre-written email to request an appointment with your members of Congress
Step 2: Print out and bring ASA’s latest report, Medical Cannabis Access for Pain Treatment: A Viable Strategy to Address the Opioid Crisis, with you.
Step 3: Print out and take with you, a copy of the CARERS Act Fact Sheet.
Step 4: Meet with your Members of Congress in your home district on the importance of medical marijuana as an alternate treatment and importance of the CARERS Act
In March, United States Senator Lindsey Graham from South Carolina signed on as a co-sponsor to the Compassionate Access, Research Expansion, and Respect States (CARERS) Act (S. 683). The CARERS Act is the most comprehensive piece of medical cannabis introduced in the history of the US Congress, and YOUR Senator signed on to it!
Unfortunately, the few who oppose medical cannabis, have been louder than the many like you who support it, and Senator Graham is feeling the pressure.
The U.S Senate has done more work on the subject of medical cannabis in the past year than any time since the passage of the Controlled Substances Act in 1970. While the Senate Appropriations Committee has taken steps to limit federal interference with state medical cannabis laws, most Senate offices are still focused on the issue of research.
While lifting barriers to research is important, it is also necessary that the federal government end the crackdown on state medical cannabis programs and the patients who rely upon them. The CARERS Act (S.683) would protect all existing state medical cannabis programs from federal interference, as well as ease restrictions surrounding research.
Please take action to let your senators know that medical cannabis patients need protection today in addition to easing restriction on research. Please call and email your senators to let them know that they should sign on to the CARERS Act in order to protect existing state medical cannabis programs and the patients who rely upon them.
And if your senator(s) have already signed on as cosponsors, please call to thank them for their support. Thanking legislators when they stand up for medical cannabis encourages them to do more on behalf of patients.